Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density

Obesity Surgery

Volumn 20, Issue 4, 2010, Pages 468-473

  Balsa, José Antonio ^a   Botella Carretero, José I ^a   Peromingo, Roberto ^a   Caballero, Carmen ^a   Muñoz Malo, Teresa ^a   Villafruela, Juan J ^a   Arrieta, Francisco ^a   Zamarrón, Isabel ^a   Vázquez, Clotilde ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Biliopancreatic diversion; Bone turnover; Secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BILIOPANCREATIC BYPASS; BLOOD SAMPLING; BODY MASS; BONE DENSITY; BONE TURNOVER; CHEMOLUMINESCENCE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENOPAUSE; MORBID OBESITY; PARTIAL GASTRECTOMY; PREDICTION; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SECONDARY HYPERPARATHYROIDISM; WEIGHT REDUCTION;

ADULT; AGED; BILIOPANCREATIC DIVERSION; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHRONIC DISEASE; COLLAGEN TYPE I; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MIDDLE AGED; OBESITY, MORBID; OSTEOCALCIN; PARATHYROID HORMONE; WEIGHT LOSS;

EID: 77953288611     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-0028-z     Document Type: Article

References (29)

1. Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998; 22: 936-946
2. Balsa JA, Botella-Carretero JI, Peromingo R, et al. Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion. J Endocrinol Invest. 2008; 31: 845-850
3. Newbury L, Dolan K, Hatzifotis M, et al. Depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg. 2003; 13: 893-895
4. Pugnale N, Giusti V, Suter M, et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord. 2003; 27: 110-116 (Pubitemid 36152788)
5. Guney E, Kisakol G, Ozgen G, et al. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg. 2003; 13: 383-388 (Pubitemid 36718457)
6. Coates PS, Fernstrom JD, Fernstrom MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab. 2004; 89: 1061-1065
7. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med. 1993; 25: 385-393
8. Gamero P, Delmas PD. New developments in biochemical markers for osteoporosis. Calcif Tissue Int. 1996; 52: S2-9.
9. Taylor AK, Lueken SA, Libanati C, et al. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am. 1994; 20: 589-607. (Pubitemid 24271579)
10. De Leo V, Ditto A, la Marca A, et al. Bone mineral, density and biochemical markers of bone turnover in peri- and postmenopausal women. Calcif Tissue Int. 2000; 66: 263-267 (Pubitemid 30151798)
11. Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994; 9: 1137-1141
12. Duda RT Jr, O'Brien JF, Katzmann JA, et al. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease. J Clin Endocrinol Metab. 1988; 66: 951-957
13. Deftos LJ, Parthemore JG, Price PA. Changes in plasma bone GLA protein during treatment of bone disease. Calcif Tissue Int. 1982; 34: 121-124
14. Brown JP, Delmas PD, Malaval L, et al. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet. 1984; 1: 1091-1093 (Pubitemid 14100805)
15. Okabe R, Nakatsuka K, Inaba M, et al. Clinical evaluation of the Elecsys β-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem. 2001; 47: 1410-1414 (Pubitemid 32678819)
16. Fledelius C, Johnsen AH, Cloos PA, et al. Characterization of urinary degradation products derived from type I collagen. Identification of a β-isomerized Asp-Gly sequence within the Cterminal telopeptide (α1) region. J Biol Chem. 1997; 272: 9755-9763 (Pubitemid 27171639)
17. Okabe R, Inabal M, Nakatsuka K, et al. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline. J Bone Miner Metab. 2004; 22: 127-131 (Pubitemid 38405041)
18. Rosenquist C, Fledelius C, Christgau S, et al. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem. 1998; 44: 2281-2289
19. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004; 8: 48-55. (Pubitemid 38117277)
20. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008; 93: 3735-3740
21. Moreiro J, Ruiz O, Perez G, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obes Surg. 2007; 17: 348-354 (Pubitemid 46659295)
22. Chapin BL, LeMar HJJ, Knodel DH, et al. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996; 131: 1048-1052
23. Nieves JW. Osteoporosis: the role of micronutrients. Am J Clin Nutr. 2005; 81: 1232S-9S.
24. Rosen C, Chesnut CH 3rd, Mallinak NJ. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab. 1997; 82: 1904-1910 (Pubitemid 127495208)
25. Dresner-Pollak R, Parker RA, Poku M, et al. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int. 1996; 59: 328-333 (Pubitemid 26367078)
26. Reeve J, Pearson J, Mitchell A, et al. Evolution of spinal bone loss and biochemical markers of bone remodelling after menopause in normal women. Calcif Tissue Int. 1995; 57: 105-110
27. Ross PD, Knowlton W Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 1996; 13: 297-302.
28. Riggs BL, Melton LJ III, O'Fallon WM. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone. 1996; 18: S197-201.
29. Marceau P, Biron S, Lebel S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg. 2002; 6: 690-698